PMGC HOLDINGS INC. Fair Value Adjustment of Warrants
PMGC HOLDINGS INC. (ELAB) reported Fair Value Adjustment of Warrants of -$1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- PMGC HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$1.38M.
- PMGC HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $681.13K.
- PMGC HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2024-12-31 was -$1.88K.
- PMGC HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2024-09-30 was -$65.47K.
- PMGC HOLDINGS INC. fair value adjustment of warrants for fiscal 2025 was -$214.17K.
- PMGC HOLDINGS INC. fair value adjustment of warrants for fiscal 2024 was -$369.16K, a 618.00% decline from fiscal 2023.
- PMGC HOLDINGS INC. fair value adjustment of warrants for fiscal 2023 was $71.27K, a 458.77% increase from fiscal 2022.
- PMGC HOLDINGS INC. fair value adjustment of warrants for fiscal 2022 was $12.75K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.38M 10-Q · filed 2026-08-14 | -$701.92K 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $681.13K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | -$214.17K 10-K · filed 2026-03-30 | |||||
| 2024-12-31 | -$1.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$67.36K derived: sum of 2 quarters · filed 2026-03-30 | -$94.22K derived: sum of 3 quarters · filed 2026-03-30 | -$369.16K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | -$65.47K 10-Q · filed 2025-11-14 | -$92.34K derived: sum of 2 quarters · filed 2025-11-14 | -$367.28K 10-Q · filed 2025-11-14 | -$747.07K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$26.86K 10-Q · filed 2025-08-13 | -$301.80K 10-Q · filed 2025-08-13 | -$681.59K derived: sum of 3 quarters · filed 2025-08-13 | -$689.78K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | -$274.94K 10-Q · filed 2025-05-14 | -$654.73K derived: sum of 2 quarters · filed 2025-05-14 | -$662.92K derived: sum of 3 quarters · filed 2025-05-14 | -$440.45K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$379.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$387.98K derived: sum of 2 quarters · filed 2025-03-28 | -$165.51K derived: sum of 3 quarters · filed 2025-03-28 | $71.27K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$8.19K 10-Q · filed 2024-11-14 | -$8.19M 10-Q · filed 2023-12-11 | $214.28K derived: sum of 2 quarters · filed 2024-11-14 | $451.05K 10-Q · filed 2024-11-14 | $451.05M 10-Q · filed 2023-12-11 | -$29.30M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $222.47K 10-Q · filed 2024-08-14 | $459.25K 10-Q · filed 2024-08-14 | -$29.29M derived: sum of 3 quarters · filed 2024-08-14 | $472.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $236.78K 10-Q · filed 2024-05-15 | -$29.51M derived: sum of 2 quarters · filed 2024-05-15 | $249.53K derived: sum of 3 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$29.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $12.75K derived: sum of 2 quarters · filed 2024-03-29 | $12.75K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $29.76M 10-Q · filed 2023-12-11 | $29.76M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |